Patents by Inventor Silvia Menendez

Silvia Menendez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8748098
    Abstract: Described herein are compositions and methods for the diagnosis, prognosis, prevention and treatment of melanoma or melanoma associated symptoms. The compositions are microRNA molecules associated with melanoma, as well as various nucleic acid molecules relating thereto or derived therefrom.
    Type: Grant
    Filed: August 8, 2012
    Date of Patent: June 10, 2014
    Assignee: New York University
    Inventors: Eva Hernando, Miguel Segura, Douglas Hanniford, Silvia Menendez
  • Publication number: 20120322743
    Abstract: Described herein are compositions and methods for the diagnosis, prognosis, prevention and treatment of melanoma or melanoma associated symptoms. The compositions are microRNA molecules associated with melanoma, as well as various nucleic acid molecules relating thereto or derived therefrom.
    Type: Application
    Filed: August 8, 2012
    Publication date: December 20, 2012
    Applicant: NEW YORK UNIVERSITY
    Inventors: Eva Hernando, Miguel F. Segura, Douglas Hanniford, Silvia Menendez
  • Patent number: 8252760
    Abstract: Described herein are compositions and methods for the diagnosis, prognosis, prevention and treatment of melanoma or melanoma associated symptoms. The compositions are microRNA molecules associated with melanoma, as well as various nucleic acid molecules relating thereto or derived therefrom.
    Type: Grant
    Filed: March 24, 2009
    Date of Patent: August 28, 2012
    Assignee: New York University
    Inventors: Eva Hernando, Miguel F. Segura, Douglas Hanniford, Silvia Menendez
  • Publication number: 20090238896
    Abstract: Described herein are compositions and methods for the diagnosis, prognosis, prevention and treatment of melanoma or melanoma associated symptoms. The compositions are microRNA molecules associated with melanoma, as well as various nucleic acid molecules relating thereto or derived therefrom.
    Type: Application
    Filed: March 24, 2009
    Publication date: September 24, 2009
    Applicant: NEW YORK UNVERSITY
    Inventors: EVA HERNANDO, MIGUEL F. SEGURA, DOUGLAS HANNIFORD, SILVIA MENENDEZ